AU Stock MarketDetailed Quotes

AGN Argenica Therapeutics Ltd

Watchlist

0.770
-0.015-1.91%

20min DelayMarket Closed Nov 1 16:00 AET

98.63MMarket Cap-14528P/E (Static)

Argenica Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2024

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

Total revenue

Cost of revenue

Gross profit

Operating expense

24.82%8.27M

52.24%6.62M

228.24%4.35M

1.33M

Selling and administrative expenses

-2.00%2.07M

20.90%2.11M

121.37%1.75M

--789.66K

-General and administrative expense

-2.00%2.07M

20.90%2.11M

121.37%1.75M

--789.66K

Research and development costs

39.66%6.02M

72.60%4.31M

499.94%2.5M

--416.05K

Other operating expenses

-10.89%181.2K

89.31%203.35K

-10.49%107.41K

--120K

Operating profit

-24.82%-8.27M

-52.24%-6.62M

-228.24%-4.35M

-1.33M

Net non-operating interest income (expenses)

219.81%191.72K

3,464.03%59.95K

824.18%1.68K

182

Non-operating interest income

214.91%192.09K

2,335.98%61K

1,139.60%2.5K

--202

Non-operating interest expense

-64.86%369

27.74%1.05K

4,010.00%822

--20

Other net income (expenses)

48.46%2.6M

575.38%1.75M

-12.49%259.1K

296.08K

Other non-operating income (expenses)

48.46%2.6M

575.38%1.75M

-12.49%259.1K

--296.08K

Income before tax

-13.80%-5.48M

-17.71%-4.82M

-297.37%-4.09M

-1.03M

Income tax

Earnings from equity interest net of tax

Net income

-13.80%-5.48M

-17.71%-4.82M

-297.35%-4.09M

-1.03M

Net income continuous operations

-13.80%-5.48M

-17.71%-4.82M

-297.35%-4.09M

---1.03M

Noncontrolling interests

Net income attributable to the company

-13.80%-5.48M

-17.71%-4.82M

-297.35%-4.09M

-1.03M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-13.80%-5.48M

-17.71%-4.82M

-297.35%-4.09M

-1.03M

Diluted earnings per share

3.64%-0.053

0.00%-0.055

-89.66%-0.055

-0.029

Basic earnings per share

3.64%-0.053

0.00%-0.055

-89.66%-0.055

-0.029

Dividend per share

Accounting Standards

US-GAAP

	(FY)Jun 30, 2024	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021
Total revenue
Cost of revenue
Gross profit
Operating expense	24.82%8.27M	52.24%6.62M	228.24%4.35M	1.33M
Selling and administrative expenses	-2.00%2.07M	20.90%2.11M	121.37%1.75M	--789.66K
-General and administrative expense	-2.00%2.07M	20.90%2.11M	121.37%1.75M	--789.66K
Research and development costs	39.66%6.02M	72.60%4.31M	499.94%2.5M	--416.05K
Other operating expenses	-10.89%181.2K	89.31%203.35K	-10.49%107.41K	--120K
Operating profit	-24.82%-8.27M	-52.24%-6.62M	-228.24%-4.35M	-1.33M
Net non-operating interest income (expenses)	219.81%191.72K	3,464.03%59.95K	824.18%1.68K	182
Non-operating interest income	214.91%192.09K	2,335.98%61K	1,139.60%2.5K	--202
Non-operating interest expense	-64.86%369	27.74%1.05K	4,010.00%822	--20
Other net income (expenses)	48.46%2.6M	575.38%1.75M	-12.49%259.1K	296.08K
Other non-operating income (expenses)	48.46%2.6M	575.38%1.75M	-12.49%259.1K	--296.08K
Income before tax	-13.80%-5.48M	-17.71%-4.82M	-297.37%-4.09M	-1.03M
Income tax	0	0	0	54
Earnings from equity interest net of tax
Net income	-13.80%-5.48M	-17.71%-4.82M	-297.35%-4.09M	-1.03M
Net income continuous operations	-13.80%-5.48M	-17.71%-4.82M	-297.35%-4.09M	---1.03M
Noncontrolling interests
Net income attributable to the company	-13.80%-5.48M	-17.71%-4.82M	-297.35%-4.09M	-1.03M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	-13.80%-5.48M	-17.71%-4.82M	-297.35%-4.09M	-1.03M
Diluted earnings per share	3.64%-0.053	0.00%-0.055	-89.66%-0.055	-0.029
Basic earnings per share	3.64%-0.053	0.00%-0.055	-89.66%-0.055	-0.029
Dividend per share
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data